Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Debt Ratio (2020 - 2022)

Mereo BioPharma (MREO) has disclosed Debt Ratio for 3 consecutive years, with 0.01 as the latest value for Q4 2022.

  • Quarterly Debt Ratio fell 94.48% to 0.01 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 0.01 through Dec 2022, changed N/A year-over-year, with the annual reading at 0.11 for FY2021, 55.63% down from the prior year.
  • Debt Ratio for Q4 2022 was 0.01 at Mereo BioPharma, down from 0.11 in the prior quarter.
  • The five-year high for Debt Ratio was 0.26 in Q4 2020, with the low at 0.01 in Q4 2022.
  • Average Debt Ratio over 3 years is 0.13, with a median of 0.11 recorded in 2021.
  • The sharpest move saw Debt Ratio crashed 55.63% in 2021, then tumbled 94.48% in 2022.
  • Over 3 years, Debt Ratio stood at 0.26 in 2020, then tumbled by 55.63% to 0.11 in 2021, then crashed by 94.48% to 0.01 in 2022.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.01, 0.11, and 0.26 for Q4 2022, Q4 2021, and Q4 2020 respectively.